Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 8743187, 8 pages
http://dx.doi.org/10.1155/2016/8743187

Research Article

Postoperative Albumin Drop Is a Marker for Surgical Stress and a Predictor for Clinical Outcome: A Pilot Study

Martin Hübner, Styliani Mantziari, Nicolas Demartines, François Pralong, Pauline Coti-Bertrand, and Markus Schäfer

Department of Visceral Surgery and Transplantation and Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland

Received 18 September 2015; Revised 26 November 2015; Accepted 29 November 2015

Academic Editor: Miguel Pera

Copyright © 2016 Martin Hübner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Surgical stress during major surgery may be related to adverse clinical outcomes and early quantification of stress response would be useful to allow prompt interventions. The aim of this study was to evaluate the acute phase protein albumin in the context of the postoperative stress response. Methods. This prospective pilot study included 70 patients undergoing frequent abdominal procedures of different magnitude. Albumin (Alb) and C-reactive protein (CRP) levels were measured once daily starting the day before surgery until postoperative day (POD) 5. Maximal Alb decrease (Alb Δ min) was correlated with clinical parameters of surgical stress, postoperative complications, and length of stay. Results. Albumin values dropped immediately after surgery by about 10 g/L ( g/L preoperatively versus  g/L at day 1, ). Alb Δ min was correlated with operation length (Pearson , ), estimated blood loss (, ), and maximal CRP values (, ). Alb Δ min levels were significantly higher in patients having complications ( versus , ) and a longer hospital stay (, ). Conclusion. Early postoperative albumin drop appeared to reflect the magnitude of surgical trauma and was correlated with adverse clinical outcomes. Its promising role as early marker for stress response deserves further prospective evaluation.

1. Introduction

Surgical interventions trigger metabolic stress responses of different magnitude, which contribute to complication rate, delayed recovery, and length of hospital stay. Primarily, the term “major abdominal surgery” remains poorly defined and includes procedure-related factors, like the type of surgical approach (laparoscopy versus laparotomy), type and extent of organ resection, operative time, and blood loss; but secondarily also patient-related factors, for example, underlying disease (benign versus malignant), nutritional status, and preexisting comorbidities, are subsumed [1–7].

Recent improvements in perioperative care aiming to modulate an overwhelming stress response have been proven to be effective. Application of enhanced recovery pathways (ERAS) has shown a decreasing effect on surgical stress and subsequently reducing complications, hospital stay, and costs after colorectal surgery [8–10]. A strict perioperative nutritional support and the use of immune-modulating formulas proved to reduce both (infectious) complications after major surgery and hospital stay. Similarly, the perioperative use of corticosteroids has been advocated recently; and preliminary results for this simple intervention are promising with regard to postoperative outcomes [11–14].

A simple and reliable parameter representing surgical stress would be clinically important to identify patients at risk and to tailor perioperative care. Thorell et al. proposed insulin resistance to quantify the stress response [15, 16]. However, insulin resistance is difficult to measure and costly and has hence never been implemented in clinical routine. For the same reasons, interleukin-6, interleukin-10, and other cytokines are used in clinical studies only [2, 4, 6, 7, 17]. Postoperative serum C-reactive protein (CRP) levels are widely used in clinical practice to assess postoperative inflammation and to predict postoperative complications [18]. A major drawback of CRP as predictor for stress-related complications is its slow kinetics [2, 7, 17, 19]. Peak values are measured only at postoperative day 2 or 3, which may be too late for early preventive interventions. Albumin is the most abundant protein in humans and widely used as nutritional marker and predictor for outcomes. In addition, albumin shows an immediate response to surgical stress and could therefore qualify to measure surgical stress and to predict a complicated postoperative course [20–22]. This particular aspect has not yet been considered for clinical use.

The aim of the present study was therefore to assess serum albumin levels as response marker for surgical stress response and potential predictor of adverse outcomes.

2. Materials and Methods

A prospective observational pilot study was conducted in the Department of Visceral Surgery, University Hospital of Lausanne (CHUV), in order to compare the perioperative metabolic profiles of patients undergoing abdominal surgery. The present analysis focuses on the acute response of albumin in the postoperative phase and its predictive potential for clinical outcome. The study was approved by the local ethical committee (Protocol number 273/11) and all included patients signed the consent form.

The study cohort included 70 patients recruited from December 2011 to July 2012. These were ten consecutive patients for seven current and representative abdominal procedures of different magnitude: laparoscopic cholecystectomy, extraperitoneal incisional hernia repair, laparoscopic and open colectomy, upper GI resections (gastrectomy or esophagectomy), and liver and pancreas resections.

Serum albumin (g/L) and C-reactive protein (CRP, mg/dL) levels were measured in a fasting state at 7 a.m. starting the day before surgery until postoperative day (POD) 5 in a standardized manner according to hospital technical guidelines. Samples on POD 0 were taken 4–6 hours postoperatively. Pertinent demographics, surgical parameters, and clinical outcome measures were prospectively recorded in anonymized form in a computerized database. Operation (OR) duration was measured by the anesthetist from incision to skin closure. Intraoperative blood loss was estimated (EBL) as joint decision (anesthetist, surgeon) by measuring aspiration fluids and soaked gauze materials. Postoperative complications were graded by severity by use of the validated Dindo-Clavien system; grades I-II were considered as minor and III-IV were considered as major complications, respectively. Mortality was documented as grade V [23]. Hospital stay was counted from the day of surgery.

Normal and nonnormal continuous variables were compared using Student’s -test and Mann-Whitney test, respectively. ANOVA test was employed for comparing multiple groups. Statistical correlation of means was tested using Pearson’s test. A value < 0.05 was considered to be statistically significant. Data analysis was performed with the Statistical Package for the Social Sciences (SPSS 14.0, Inc., Chicago, IL).

3. Results

Demographic and surgical details of the study cohort are displayed by type of surgery in Table 1. Postoperative complications are shown in detail for each group in Table 2, according to the Dindo-Clavien classification [23].

Table 1: Demographics and surgical details.

Cholecystectomy
Incisional hernia
Laparosc. colon res.
Open colon res.
Upper GI resection
Liver resection
Pancreas resection

Age (years)
61 ± 14
74 ± 10
57 ± 14
67 ± 9
49 ± 13
61 ± 16
64 ± 20

Gender (m/f)
6/4
6/4
7/3
7/3
8/2
7/3
7/3

BMI (kg/m²)
28 ± 3
27 ± 6
26 ± 7
27 ± 4
25 ± 4
24 ± 3
25 ± 3

OR time (min)
65 ± 21
121 ± 48
201 ± 66
305 ± 120
293 ± 112
283 ± 111
329 ± 100

EBL (mL)
0
28 ± 67
79 ± 80
410 ± 448
312 ± 203
1039 ± 1463
550 ± 428

Values are expressed as mean ± SD.

BMI: body mass index; OR time: operation room time; EBL: estimated.

Table 2: Complications according to Dindo-Clavien, according to the type of surgery [23].

No complication
Minor complication (I-II)
Major complication (III-IV)
Mortality (V)

Cholecystectomy
10
0
0
0

Incisional hernia
4
5
1
0

Laparoscopic colectomy
6
4
0
0

Open colectomy
2
4
4
0

Upper GI resections
3
5
2
0

Liver resections
3
3
4
0

Pancreatic resections
1
8
0
1

3.1. Metabolic Stress Response (Figure 1)

CRP levels were  mg/dL preoperatively. They increased slowly after surgery and peaked at POD 2 ( mg/dL, ) before slowly decreasing again. Albumin values dropped immediately after surgery by about 10 g/L ( versus  g/L, ) and showed a very slow recovery. Hematocrit levels decreased in the same time period from % to % (); the resulting difference of % corresponded to a relative postoperative decrease of 7.1%.

(a) C-reactive protein

(b) Albumin

Figure 1: Acute inflammatory response after abdominal surgery as reflected by albumin and CRP kinetics. C-reactive protein (CRP) and albumin were measured preoperatively (pre-OP), 6 hours after surgery, and on postoperative days (POD) 1–5. CRP levels peaked (CRP Δ max) on POD 2 (a), while minimal albumin levels (Alb Δ min) were measured already 6 hours after surgery (b).

3.2. CRP versus Albumin: Correlation and Differences

Maximal CRP increase (CRP Δ max) and albumin decrease (Alb Δ min) were significantly correlated with each other (Pearson , ) as shown in Figure 2. Striking differences were noted though between the two parameters. (I) Baseline CRP levels were close to 0 for most of the patients, while baseline albumin showed greater variation. (II) Maximal amplitude was reached for albumin 4–6 h after surgery and for CRP on POD 2 only (Figure 1). (III) The magnitude of four representative open major resections appeared to be equally represented by albumin measurements while the surgical stress of liver resections was underestimated by CRP levels (liver versus other: versus  mg/dL, ; Figures 3(a) and 3(b)).

Figure 2: Correlation of postoperative CRP increase and albumin drop. Maximal C-reactive protein levels (CRP Δ max) are plotted against postoperative albumin drops (Alb Δ min).

(a) CRP

(b) Albumin

Figure 3: CRP levels and Albumin drop after different major surgery procedures. Maximal C-reactive protein levels (CRP Δ max) for major colon, upper gastrointestinal, liver, and pancreatic resections (a) showing significant lower values for liver resections. Postoperative albumin decrease (Alb Δ min) was equally high for the four different types of surgery (b).

3.3. Correlation of Albumin Drop with Surrogate Parameters for Surgical Magnitude

Median OR duration and estimated blood loss were 200 min (IQR 217) and 150 mL (IQR 400), respectively, for the entire cohort. Albumin decrease showed linear correlation to OR duration (Figure 4, Pearson , ) and estimated blood loss (online appendix available online at http://dx.doi.org/10.1155/2016/8743187, Pearson , ).

Figure 4: Correlation between albumin drop and operative time. Postoperative albumin decrease (Alb Δ min) is significantly correlated with operative time (Pearson , ).

3.4. Correlation of Albumin Drop with Clinical Outcome Measures

Alb Δ min values were estimated for all patient groups in relation to postoperative complications (online appendix). There was a trend of higher Alb Δ min levels in patients with major complications () and a significant difference comparing patients with no complication with the group with any complication ( versus  g/L, ). Albumin drop and length of hospital stay were statistically correlated (Pearson , ) as shown in Figure 5.

Figure 5: Albumin drop and hospital stay. Alb Δ min shows a positive correlation with increased length of hospital stay (Pearson ,  ).

4. Discussion

This pilot study evaluated serum albumin kinetics as response marker for surgical stress and predictor of adverse postoperative outcome of seven different surgical interventions. Our findings suggest that postoperative albumin decrease (Alb Δ min) reliably quantifies the magnitude of surgery and may be used as predictor for a complicated postoperative course. It can be assessed as early as 4–6 hours after surgery.

Major surgery is followed by an important metabolic stress response, which is closely related to adverse outcomes [2, 3, 7, 15]. A number of perioperative interventions allow modulating an excessive stress response, some of them having an important positive impact on clinical outcome [1, 5, 7, 9, 11, 24, 25]. Therefore, reliable prediction of surgical stress response is of high interest. The ideal marker has to be easy to measure, available early in the perioperative course, and inexpensive. It should be strongly correlated with the extent of surgical trauma and be a reliable predictor of complications and prolonged hospital stay. So far, no such parameter is available [4, 7, 26].

Stress response after surgery and trauma has been extensively studied and it involves important hormonal, electrolytic, and metabolic changes and liberation of cytokines [2, 6, 27, 28]. IL-6 is a proinflammatory cytokine that correlates with postoperative insulin resistance [29–31] and the magnitude of (surgical) trauma and increases hours after the hit [6, 27, 32, 33]. However, sophisticated and expensive measuring renders its routine use impracticable.

The role of acute phase proteins was investigated in our study by means of CRP levels and the decrease of serum albumin. CPR levels correlate closely with the magnitude of surgery and are routinely assessed to monitor postoperative systemic inflammatory response [1–3, 7, 17, 19]. The use of CRP levels on POD 4 has also been advocated as predictor for (infectious) complications [18]. However, kinetics are rather slow, and plasma peaks are only reached between POD 2 and POD 3. This is an important limitation, as potential therapeutic interventions should be launched as early as possible. Furthermore, CRP is produced in the liver, and its production is significantly impaired in patients with liver disease or after hepatectomy as shown in this present study. CRP may therefore not be an appropriate marker for surgical stress in patients undergoing liver surgery [19].

Serum albumin is widely used as reliable indicator for nutritional status and as predictor for clinical outcomes. The present study focused on the potential value of early postoperative serum albumin drop to measure surgical magnitude and predict the related adverse outcomes. Albumin accounts for 55–60% of protein in human plasma. About two-thirds of the total body albumin pool is in the extravascular space; exchange with the intravascular compartment (30–40%) takes place under physiological conditions at a rate of about 5%/h. Albumin is produced exclusively in the liver representing 50% of the organ’s protein synthesis and can be upregulated up to threefold if the oncotic pressure decreases. Albumin degradation takes place in various organs, in a rate of about 5% per day given a half-life of 19 days; of note, plasma half-life of injected albumin is only one day due to redistribution into the extravascular compartment. Thus, serum albumin concentration depends basically on three factors, synthesis, distribution, and degradation [20, 34].

The combination of serum CRP and albumin changes has been correlated with adverse clinical outcomes. For instance, the Glasgow Prognostic Score (GPS) and modified GPS have been described for the prediction of survival in surgical patients, assigning to elevated CRP and lowered albumin levels a clearly negative prognostic value [35, 36]. Recently, Ishizuka and colleagues [37] found a significant correlation of an elevated CRP to albumin ratio with negative oncological outcomes in colorectal cancer patients, and Ranzani et al. [38] confirmed similar results in septic patients. The CRP/albumin ratio combines indeed information on nutritional and inflammatory status and could thus be a reliable marker of negative outcome. Our study confirms the aforementioned hypothesis and also focuses on the promptness of albumin decrease only hours after the surgical trauma, which has not yet been assessed and validated in the clinical setting.

Protein metabolism is significantly disturbed after any kind of traumatic event, for example, surgery, sepsis, and burn injuries [39, 40]; albumin has been identified as a reliable indicator of this process [34, 40, 41]. Plasma concentrations of albumin reveal an important decrease as early as a few hours after the hit [21, 34, 40, 41]. Yet, conflicting results from experimental and human studies still hamper a complete understanding of underlying pathophysiological mechanisms. (I) The importance of acute phase proteins during the early postoperative phase impairs hepatic albumin synthesis, to facilitate the production of these acute phase molecules (CRP, fibrinogen, and macroglobulin) needed in the host defense process [2, 40]. However, this initial decrease is transitory. Fractional albumin synthesis increases in the early postoperative period proportionally to the degree of inflammation; production can be further stimulated by perioperative nutrition [34]. (II) Basal energy expenditure increases nearly 10-fold in the early postoperative phase, and up to 20% of the body’s store in protein can be consumed within ten days to favor glyconeogenesis [27]. (III) The most important postoperative losses of albumin however are due to sequestration into the third space. Capillary leak is a well-known phenomenon in the context of sepsis and (surgical) trauma [3, 28, 42]. Fleck et al. described already in 1985 that transcapillary exchange rate increased by 100% after major surgery and up to 300% in patients with septic shock [20, 41]. The increase in capillary escape rate occurs only hours after the offending trauma and can be twice as high in cachectic patients [20–22]. Perioperative nutrition will therefore decrease albumin losses not only by increasing hepatic synthesis as described above but also by decreasing losses in the extravascular space [20, 34]. Since the physiological efflux rate of 5%/h already represents about 10 times the rate of albumin synthesis and catabolism, it appears that capillary leak due to the metabolic stress response probably represents the principal mechanism of postoperative albumin drops [28, 34, 41]. A previous study estimated that 77% of the postoperative albumin decrease was due to redistribution, while 18% and 6% were attributed to blood loss and catabolism, respectively, [22]. Of note, transcapillary exchange rate clearly depended on the underlying trauma, and no increase was noted after minor surgery [20, 22].

Hemodilution is a potential confounder that needs to be taken into the equation of postoperative albumin decrease. In the present study, albumin dropped immediately by 20% from the baseline values, while hematocrit values diminished in the same time period by 7% only. This suggests that hemodilution played only a subsidiary role in postoperative albumin decrease, an observation consistent with previously published data [21, 22]. Also, the recent ALBIOS trial failed to demonstrate any benefit of albumin substitution in septic patients [43], suggesting that postoperative hypoalbuminemia represents an indicator rather than a cause of adverse outcomes.

In our study, albumin was strongly correlated with CRP levels but was available earlier in the postoperative course. It was strongly correlated with reliable surrogate parameters of the extent of surgery (OR duration, blood loss). The slow recovery of serum albumin during the first five postoperative days confirms previously published findings of Rittler et al. [40], who described a normalization of serum albumin levels by progressive reduction of initially increased albumin synthesis after open rectal resection.

Further, high Alb Δ min levels were associated with postoperative morbidity and prolonged hospital stay. Ryan et al. recently studied albumin changes one day after esophagectomy and associated low serum albumin <20 g/L with increased morbidity, longer intensive care unit stay, and higher reoperation rates [21]. Of note, the absolute baseline value of albumin can be influenced by preoperative hypoalbuminemia and thus malnutrition, which is an established risk factor for adverse outcomes [44]. Therefore, the postoperative decrease in albumin in relation to its preoperative levels appears to be more reliable. Furthermore, albumin drop can already be measured hours after surgery, as in our study, and not only on the day after [20–22, 41]. This is of importance as several interventions exist to attenuate the postoperative metabolic stress response [4, 7, 11, 14, 24, 25] and thus early identification of patients at risk is appealing. Lastly in practical terms, serum albumin is part of the routine work-up before major surgery and inexpensive and seems to reflect metabolic stress even after liver surgery to the same extent as after other major organ resections (Figure 3(b)).

Several limitations need to be addressed. This pilot study aimed at studying metabolic profiles after different surgical procedures. The modest and heterogeneous study cohort did not allow identifying meaningful cut-off values for albumin drop by means of a receiver operating characteristic (ROC) curve and hence calculating sensitivity, specificity, and predictive values. Our findings concerning albumin’s role as acute phase protein need to be tested in larger patient samples to identify meaningful cut-off values and to guide therapeutic measures. These are the aims of our ongoing large prospective cohort study (NCT02356484). It remains further to be determined whether postoperative albumin decrease could be useful also for other types of surgeries or critically ill patients.

5. Conclusion

In summary, postoperative decrease in serum albumin was found in the present study to reflect the magnitude of surgery and the associated stress response. Whilst hypoalbuminemia (absolute serum values) is well established for nutritional assessment and prediction of complications, the early postoperative albumin decrease (delta from baseline) has not yet been implemented into clinical management. Postoperative albumin drops were strongly correlated with CRP increase but could already be measured 4–6 hours after surgery; albumin response was further related to clinical outcomes. This observation could be of clinical importance, since modulation of an overshooting stress response can be achieved by pharmacological and nutritional interventions as well as by specific modifications in perioperative care. This hypothesis needs confirmation and is currently tested in a prospective cohort study (NCT02356484).

Abbreviations

Alb: | Albumin
CRP: | C-reactive protein
POD: | Postoperative day
Alb Δ min: | Maximal albumin decrease.

Conflict of Interests

The authors declare no conflict of interests.

Acknowledgments

The authors would like to thank all colleagues in the Visceral Surgery department and the Clinical Nutrition team for their kind collaboration as well as the nursing staff in visceral surgery and Mrs. Giustina Mariotti, clinical research nurse, for their invaluable help with blood sampling.

References

M. Buunen, M. Gholghesaei, R. Veldkamp, D. W. Meijer, H. J. Bonjer, and N. D. Bouvy, “Stress response to laparoscopic surgery: a review,” Surgical Endoscopy and Other Interventional Techniques, vol. 18, no. 7, pp. 1022–1028, 2004.

J. P. Desborough, “The stress response to trauma and surgery,” British Journal of Anaesthesia, vol. 85, no. 1, pp. 109–117, 2000.

Y. Haga, T. Beppu, K. Doi et al., “Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery,” Critical Care Medicine, vol. 25, no. 12, pp. 1994–2000, 1997.

R. Hall, “Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 27, no. 5, pp. 983–1033, 2013.

S. Karanika, T. Karantanos, and G. E. Theodoropoulos, “Immune response after laparoscopic colectomy for cancer: a review,” Gastroenterology Report, vol. 1, no. 2, pp. 85–94, 2013.

E. Lin, S. E. Calvano, and S. F. Lowry, “Inflammatory cytokines and cell response in surgery,” Surgery, vol. 127, no. 2, pp. 117–126, 2000.

P. E. Marik and M. Flemmer, “The immune response to surgery and trauma: implications for treatment,” Journal of Trauma and Acute Care Surgery, vol. 73, no. 4, pp. 801–808, 2012.

M. M. E. Coolsen, R. M. van Dam, A. A. van der Wilt, K. Slim, K. Lassen, and C. H. C. Dejong, “Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies,” World Journal of Surgery, vol. 37, no. 8, pp. 1909–1918, 2013.

M. Greco, G. Capretti, L. Beretta, M. Gemma, N. Pecorelli, and M. Braga, “Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials,” World Journal of Surgery, vol. 38, no. 6, pp. 1531–1541, 2014.

S. Muller, M. P. Zalunardo, M. Hubner, P. A. Clavien, and N. Demartines, “A fast-track program reduces complications and length of hospital stay after open colonic surgery,” Gastroenterology, vol. 136, no. 3, pp. 842–847, 2009.

K. Karaman, E. B. Bostanci, E. Aksoy et al., “Effects of dexamethasone and pheniramine hydrogen maleate on stress response in patients undergoing elective laparoscopic cholecystectomy,” American Journal of Surgery, vol. 205, no. 2, pp. 213–219, 2013.

E. Kilger, J. Heyn, A. Beiras-Fernandez, B. Luchting, and F. Weis, “Stress doses of hydrocortisone reduce systemic inflammatory response in patients undergoing cardiac surgery without cardiopulmonary bypass,” Minerva Anestesiologica, vol. 77, no. 3, pp. 268–274, 2011.

L. A. Orci, C. Toso, G. Mentha, P. Morel, and P. E. Majno, “Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection,” British Journal of Surgery, vol. 100, no. 5, pp. 600–609, 2013.

N. H. Waldron, C. A. Jones, T. J. Gan, T. K. Allen, and A. S. Habib, “Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis,” British Journal of Anaesthesia, vol. 110, no. 2, pp. 191–200, 2013.

A. Thorell, S. Efendic, M. Gutniak, T. Haggmark, and O. Ljungqvist, “Development of postoperative insulin resistance is associated with the magnitude of operation,” European Journal of Surgery, Acta Chirurgica, vol. 159, no. 11-12, pp. 593–599, 1993.

A. Thorell, J. Nygren, and O. Ljungqvist, “Insulin resistance: a marker of surgical stress,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 2, no. 1, pp. 69–78, 1999.

R. Easton and Z. J. Balogh, “Peri-operative changes in serum immune markers after trauma: a systematic review,” Injury, vol. 45, no. 6, pp. 934–941, 2014.

R. Warschkow, U. Beutner, T. Steffen et al., “Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients,” Annals of Surgery, vol. 256, no. 2, pp. 245–250, 2012.

C. Lelubre, S. Anselin, K. Zouaoui Boudjeltia, P. Biston, and M. Piagnerelli, “Interpretation of c-reactive protein concentrations in critically Ill patients,” BioMed Research International, vol. 2013, Article ID 124021, 11 pages, 2013.

A. Fleck, G. Raines, F. Hawker et al., “Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury,” The Lancet, vol. 325, no. 8432, pp. 781–784, 1985.

A. M. Ryan, A. Hearty, R. S. Prichard, A. Cunningham, S. P. Rowley, and J. V. Reynolds, “Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy,” Journal of Gastrointestinal Surgery, vol. 11, no. 10, pp. 1355–1360, 2007.

H. J. Smeets, J. Kievit, F. T. Dulfer, J. Hermans, and A. J. Moolenaar, “Analysis of post-operative hypalbuminaemia: a clinical study,” International Surgery, vol. 79, no. 2, pp. 152–157, 1994.

D. Dindo, N. Demartines, and P.-A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Annals of Surgery, vol. 240, no. 2, pp. 205–213, 2004.

Y. Cerantola, M. Hübner, F. Grass, N. Demartines, and M. Schäfer, “Immunonutrition in gastrointestinal surgery,” British Journal of Surgery, vol. 98, no. 1, pp. 37–48, 2011.

J. H. Park, D. C. McMillan, P. G. Horgan, and C. S. Roxburgh, “The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer,” Cancer Treatment Reviews, vol. 40, no. 1, pp. 68–77, 2014.

D. Bugada, M. Allegri, P. Lavand'Homme, M. De Kock, and G. Fanelli, “Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients,” BioMed Research International, vol. 2014, Article ID 142425, 11 pages, 2014.

A. G. Hill and G. L. Hill, “Metabolic response to severe injury,” British Journal of Surgery, vol. 85, no. 7, pp. 884–890, 1998.

J. A. Russell, “Management of sepsis,” The New England Journal of Medicine, vol. 355, no. 16, pp. 1699–1713, 2006.

P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan, “Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance,” American Journal of Physiology—Endocrinology and Metabolism, vol. 280, no. 5, pp. E745–E751, 2001.

J. Spranger, A. Kroke, M. Möhlig et al., “Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study,” Diabetes, vol. 52, no. 3, pp. 812–817, 2003.

B. Vozarova, C. Weyer, K. Hanson, P. A. Tataranni, C. Bogardus, and R. E. Pratley, “Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion,” Obesity Research, vol. 9, no. 7, pp. 414–417, 2001.

S. Glund and A. Krook, “Role of interleukin-6 signalling in glucose and lipid metabolism,” Acta Physiologica, vol. 192, no. 1, pp. 37–48, 2008.

G. van Hall, A. Steensberg, M. Sacchetti et al., “Interleukin-6 stimulates lipolysis and fat oxidation in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 7, pp. 3005–3010, 2003.

A. Hülshoff, T. Schricker, H. Elgendy, R. Hatzakorzian, and R. Lattermann, “Albumin synthesis in surgical patients,” Nutrition, vol. 29, no. 5, pp. 703–707, 2013.

S. Dutta, A. B. C. Crumley, G. M. Fullarton, P. G. Horgan, and D. C. McMillan, “Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer,” World Journal of Surgery, vol. 35, no. 8, pp. 1861–1866, 2011.

D. C. McMillan, “The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer,” Cancer Treatment Reviews, vol. 39, no. 5, pp. 534–540, 2013.

M. Ishizuka, H. Nagata, K. Takagi, Y. Iwasaki, N. Shibuya, and K. Kubota, “Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer,” Annals of Surgical Oncology, pp. 1–8, 2015.

O. T. Ranzani, F. G. Zampieri, D. N. Forte, L. C. P. Azevedo, and M. Park, “C-reactive protein/albumin ratio predicts 90-day mortality of septic patients,” PLoS ONE, vol. 8, no. 3, Article ID e59321, 2013.

D. W. Hart, S. E. Wolf, R. Mlcak et al., “Persistence of muscle catabolism after severe burn,” Surgery, vol. 128, no. 2, pp. 312–319, 2000.

P. Rittler, R. Jacobs, H. Demmelmair et al., “Dynamics of albumin synthesis after major rectal operation,” Surgery, vol. 141, no. 5, pp. 660–666, 2007.

A. Fleck, C. M. Colley, and M. A. Myers, “Liver export proteins and trauma,” British Medical Bulletin, vol. 41, no. 3, pp. 265–273, 1985.

W. L. Lee and A. S. Slutsky, “Sepsis and endothelial permeability,” The New England Journal of Medicine, vol. 363, no. 7, pp. 689–691, 2010.

P. Caironi, G. Tognoni, S. Masson et al., “Albumin replacement in patients with severe sepsis or septic shock,” The New England Journal of Medicine, vol. 370, no. 15, pp. 1412–1421, 2014.

A. Weimann, M. Braga, L. Harsanyi et al., “ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation,” Clinical Nutrition, vol. 25, no. 2, pp. 224–244, 2006.